8-KThe WireRoutine
Shareholder Vote
Filed May 9, 2024 · 2y ago · Accession 0001104659-24-059338
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Theravance Biopharma, Inc.
- Ticker
- TBPH
- CIK
- 1583107
- Form type
- 8-K
- Filing date
- May 9, 2024
- Report date
- May 8, 2024
- Document
- tm2413991d1_8k.htm
- Size
- 208 KB